Viking Global Investors’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-490,035
| Closed | -$10.8M | – | 91 |
|
|
2025
Q1 | $10.8M | Sell |
490,035
-734,951
| -60% | -$16.2M | 0.03% | 87 |
|
|
2024
Q4 | $32.7M | Sell |
1,224,986
-256,160
| -17% | -$6.84M | 0.11% | 80 |
|
|
2024
Q3 | $39.5M | Hold |
1,481,146
| – | – | 0.14% | 76 |
|
|
2024
Q2 | $26.7M | Sell |
1,481,146
-1,858,000
| -56% | -$33.5M | 0.1% | 77 |
|
|
2024
Q1 | $60.9M | Sell |
3,339,146
-2,820,000
| -46% | -$51.4M | 0.23% | 69 |
|
|
2023
Q4 | $67.4M | Hold |
6,159,146
| – | – | 0.25% | 64 |
|
|
2023
Q3 | $35.3M | Buy |
6,159,146
+215,885
| +4% | +$1.24M | 0.14% | 70 |
|
|
2023
Q2 | $46.1M | Buy |
5,943,261
+1,034,115
| +21% | +$8.01M | 0.19% | 75 |
|
|
2023
Q1 | $32.7M | Buy |
4,909,146
+500,000
| +11% | +$3.34M | 0.15% | 69 |
|
|
2022
Q4 | $39.4M | Hold |
4,409,146
| – | – | 0.2% | 65 |
|
|
2022
Q3 | $43.4M | Buy |
4,409,146
+1,681,897
| +62% | +$16.5M | 0.2% | 71 |
|
|
2022
Q2 | $21.7M | Hold |
2,727,249
| – | – | 0.1% | 77 |
|
|
2022
Q1 | $26.5M | Hold |
2,727,249
| – | – | 0.11% | 82 |
|
|
2021
Q4 | $41.7M | Hold |
2,727,249
| – | – | 0.12% | 89 |
|
|
2021
Q3 | $45.3M | Hold |
2,727,249
| – | – | 0.12% | 83 |
|
|
2021
Q2 | $58.2M | Sell |
2,727,249
-625,000
| -19% | -$13.3M | 0.18% | 73 |
|
|
2021
Q1 | $109M | Buy |
+3,352,249
| New | +$109M | 0.32% | 64 |
|